1. Home
  2. ABVX vs LW Comparison

ABVX vs LW Comparison

Compare ABVX & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$118.85

Market Cap

9.0B

Sector

N/A

ML Signal

HOLD

Logo Lamb Weston Holdings Inc.

LW

Lamb Weston Holdings Inc.

HOLD

Current Price

$41.79

Market Cap

8.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABVX
LW
Founded
2013
1950
Country
France
United States
Employees
N/A
N/A
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ABVX
LW
Price
$118.85
$41.79
Analyst Decision
Strong Buy
Buy
Analyst Count
12
7
Target Price
$122.00
$56.14
AVG Volume (30 Days)
2.0M
4.0M
Earning Date
08-11-2025
12-19-2025
Dividend Yield
N/A
3.67%
EPS Growth
N/A
9.13
EPS
N/A
2.78
Revenue
$6,231,374.00
$6,473,600,000.00
Revenue This Year
$6.80
$4.13
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$14.93
Revenue Growth
N/A
2.35
52 Week Low
$4.77
$39.79
52 Week High
$148.83
$67.07

Technical Indicators

Market Signals
Indicator
ABVX
LW
Relative Strength Index (RSI) 47.24 27.48
Support Level $108.95 $39.79
Resistance Level $129.64 $41.61
Average True Range (ATR) 8.13 1.02
MACD -2.53 0.23
Stochastic Oscillator 27.08 68.18

Price Performance

Historical Comparison
ABVX
LW

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About LW Lamb Weston Holdings Inc.

Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.

Share on Social Networks: